Medicine and Dentistry
Nodular Melanoma
100%
Neoplasm
46%
Sentinel Lymph Node
40%
Biopsy
35%
Sentinel Lymph Node Biopsy
30%
Sentinel Node
27%
Recurrent Disease
24%
Malignant Neoplasm
24%
Metastatic Carcinoma
22%
Cutaneous Melanoma
21%
Breast Cancer
20%
Surgery
18%
Gene Expression
18%
Overall Survival
17%
Disease
16%
Retroperitoneal Lymph Node Dissection
14%
Surgeon
13%
Breast Tumor
12%
Triple Test
11%
Health Care Cost
10%
Neck
10%
Recurrence Free Survival
9%
Sentinel Lymph Node Metastasis
8%
Tumor Infiltrating Lymphocyte
8%
Decision Making
8%
Fine-Needle Aspiration
7%
Oncology
7%
Gene Expression Profiling
7%
Adjuvant Therapy
7%
Lymph Node
7%
Surgical Oncology
7%
Primary Tumor
7%
Interleukin 2
6%
Drug Megadose
6%
Predictive Factor
6%
Physical Examination
6%
Survival Rate
6%
Venous Ulcer
6%
Recurrence Risk
5%
Recombinant Interleukin 2
5%
Breast Cancer Screening
5%
Lung Cancer
5%
Melanoma
5%
Disease Free Survival
5%
Colorectal Cancer
5%
Hazard Ratio
5%
T Cell
5%
Clinical Trial
5%
Keyphrases
Melanoma
40%
Sentinel Lymph Node Biopsy
22%
Sentinel Lymph Node
17%
Interleukin-2
11%
Metastatic Melanoma
11%
Melanoma Patients
10%
Breast Cancer
9%
Triple Test
9%
Melanoma-specific Survival
8%
Tumor
8%
Tumor-infiltrating Lymphocytes
8%
Overall Survival
8%
Recombinant interleukin-2
7%
Surgical Oncology
6%
31-gene Expression Profile
6%
Lymphokine-activated Killer Cells
6%
Palpable Breast Mass
6%
Tumor Burden
6%
Breast
5%
OX40
5%
Thick Melanoma
5%
Recurrence-free Survival
5%
Fine-needle Aspiration
5%
High Risk
5%
Sentinel Lymph Node Metastasis
5%
Surveillance Imaging
5%